Streetbeat News

Stock Prices

VST

Vistra (NYSE:VST) has seen a 20.45% increase in its short percent of float, now at 4.83% of all regular shares available for trading. This is higher than the peer group average of 1.94%. The increase in short interest could indicate bearish sentiment, but it doesn't necessarily mean the stock will fall in the near term.

Portfolio Pulse from Benzinga Insights

June 24, 2024 | 4:30 pm

PUK

Prudential plc (NYSE:PUK) has announced a $2 billion share buyback program, leading to a 7.97% increase in its stock price. The company aims to complete the buyback by mid-2026 and expects its 2024 annual dividend to grow by 7-9%. Prudential's free surplus ratio is currently at 242%, well above its target range of 175-200%.

Portfolio Pulse from Lekha Gupta

June 24, 2024 | 4:24 pm

KSCP

Knightscope shares are trading higher after the company announced it signed a contract with a city in Texas for three K1 Blue Light Towers.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 4:17 pm

CG

FMCX

KKR

LBO

KKR & Co Inc (NYSE:KKR) is targeting $20 billion for its new North America private equity fund, North America Fund XIV, amid a challenging fundraising environment. The fund aims for a high teens net IRR and plans to deploy 20%-25% of its capital annually. KKR's previous fund achieved a net IRR of 20.5%. The firm's fundraising efforts will test investor confidence, especially compared to Carlyle Group Inc (NASDAQ:CG) and Bain Capital's funds. KKR has raised $180 billion from early 2022 to Q1 2024 and has committed to offering equity to employees of its portfolio companies, leading to higher revenue and lower turnover. KKR stock has gained over 105% in the last 12 months.

Portfolio Pulse from Shivani Kumaresan

June 24, 2024 | 4:17 pm

AGG

BND

BNDX

Markets are expecting the neutral rate to stay higher than policymakers forecast, which may limit the Federal Reserve's ability to cut interest rates and create headwinds for bond ETFs. This could impact the performance of bond ETFs like iShares Core U.S. Aggregate Bond ETF (AGG), Vanguard Total Bond Market Index Fund (BND), and Vanguard Total International Bond Index Fund (BNDX).

Portfolio Pulse from Michael Juliano

June 24, 2024 | 4:16 pm

CKPT

Checkpoint Therapeutics shares are trading higher after the company announced it reached alignment with the FDA on its biologics license application resubmission strategy for cosibelimab.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 4:12 pm

REVB

Revelation Biosciences Inc (NASDAQ:REVB) announced positive safety and biomarker data for its Phase 1 study of Gemini, leading to a 31.30% increase in its stock price. The study met its primary endpoint, showing significant dose-dependent upregulation of key biomarkers and was well-tolerated. The company plans to move into a Phase 1b study in late 2024.

Portfolio Pulse from Vandana Singh

June 24, 2024 | 4:06 pm

OMIC

Singular Genomics shares are trading lower after the company announced a 1-for-30 reverse stock split.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 4:03 pm

REGN

Thirteen analysts have recently published ratings on Regeneron Pharmaceuticals (NASDAQ:REGN), with a mix of bullish, somewhat bullish, indifferent, and somewhat bearish sentiments. The average 12-month price target is $1069.69, reflecting a slight increase from the previous average. Key analysts have maintained or raised their ratings and price targets, indicating a generally positive outlook despite some financial challenges.

Portfolio Pulse from Benzinga Insights

June 24, 2024 | 4:01 pm

EBS

Emergent BioSolutions (NYSE:EBS) has received diverse analyst ratings over the past three months, with a mix of bullish and somewhat bullish outlooks. Analysts have set a 12-month price target range of $5.00 to $8.00, with an average target of $7.25. The company's recent financial performance shows strong revenue growth and profitability, but it carries a substantial amount of debt.

Portfolio Pulse from Benzinga Insights

June 24, 2024 | 4:00 pm